We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arcturus Therapeutics
ARCT
$164M
| $30.7M | 0.36% |
1,069,814
+251,376
| +31% | +$6.84M |
|
77
Comstock Resources
CRK
$3.89B
| $30.4M | 0.36% |
+2,624,405
| New | +$27.3M |
|
78
Intel
INTC
$455B
| $30.3M | 0.36% |
906,852
-732,345
| -45% | -$23M |
|
79
Synopsys
SNPS
$74.4B
| $30.2M | 0.36% |
69,257
-91,417
| -57% | -$36.8M |
|
80
Vontier
VNT
$4.52B
| $30M | 0.36% |
931,117
-136,343
| -13% | -$3.93M |
|
|
SYNH
81
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $29.6M | 0.35% |
703,500
+591,291
| +527% | +$23.9M |
|
82
US Foods
USFD
$22.2B
| $29.3M | 0.35% |
+665,220
| New | +$26.4M |
|
83
Thermo Fisher Scientific
TMO
$213B
| $29.1M | 0.34% |
+55,687
| New | +$30.1M |
|
|
PDCE
84
DELISTED
PDC Energy, Inc.
PDCE
| $28.8M | 0.34% |
+404,460
| New | +$27.3M |
|
85
RadNet
RDNT
$5.02B
| $28.4M | 0.34% |
871,077
+370,338
| +74% | +$10.8M |
|
|
MORF
86
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $28.3M | 0.34% |
494,429
+144,429
| +41% | +$7.54M |
|
|
JNPR
87
DELISTED
Juniper Networks
JNPR
| $28.3M | 0.34% |
902,604
+115,817
| +15% | +$3.57M |
|
88
NXP Semiconductors
NXPI
$57.8B
| $28.2M | 0.33% |
137,987
-62,322
| -31% | -$11.1M |
|
89
DuPont de Nemours
DD
$18.5B
| $28.2M | 0.33% |
+314,193
| New | +$27M |
|
90
Vera Therapeutics
VERA
$2.3B
| $28.1M | 0.33% |
1,753,690
+972
| +0.1% | +$8.78K |
|
91
Bentley Systems
BSY
$10.8B
| $26.9M | 0.32% |
495,481
+100,170
| +25% | +$4.67M |
|
92
APA Corp
APA
$13.2B
| $26.9M | 0.32% |
+785,946
| New | +$27.4M |
|
|
OKLO
93
Oklo
OKLO
$6.76B
| $26.5M | 0.31% |
2,537,937
+945,645
| +59% | +$9.85M |
|
94
Allogene Therapeutics
ALLO
$649M
| $26.4M | 0.31% |
5,313,500
+3,121,070
| +142% | +$16.9M |
|
|
FOCS
95
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $26.4M | 0.31% |
502,501
+309,802
| +161% | +$16.1M |
|
96
Amazon
AMZN
$2.92T
| $26.4M | 0.31% |
202,409
-291,836
| -59% | -$33.3M |
|
97
DexCom
DXCM
$31.5B
| $26.2M | 0.31% |
204,029
+190,697
| +1,430% | +$23.1M |
|
|
ESTE
98
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $25.5M | 0.3% |
+1,785,599
| New | +$23.8M |
|
99
Avantor
AVTR
$9.32B
| $25.4M | 0.3% |
+1,236,646
| New | +$25M |
|
|
CERE
100
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $25.3M | 0.3% |
794,919
+183,553
| +30% | +$5.63M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.